HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
27 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PLG
plasminogen
Chromosome 6 Β· 6q26
NCBI Gene: 5340Ensembl: ENSG00000122194.20HGNC: HGNC:9071UniProt: P00747
440PubMed Papers
22Diseases
9Drugs
28Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneProtease
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protease bindingendopeptidase activityserine-type endopeptidase activitysignaling receptor bindinghypoplasminogenemiahereditary angioedemadysplasminogenemiahemorrhage
✦AI Summary

Plasminogen (PLG) is a circulating zymogen that serves as the precursor to plasmin, a broad-spectrum serine protease with critical roles in fibrinolysis and tissue homeostasis 1. PLG is activated on cell surfaces through interaction with plasminogen receptors, particularly Plg-RKT, which tethers PLG via C-terminal lysine residues and promotes its conversion to the active plasmin protease 2. This cell surface activation enables localized proteolytic activity that facilitates extracellular matrix degradation, immune cell migration, and inflammatory resolution 3. Beyond hemostasis, PLG participates in pathological processes: severe hypoplasminogenemia causes ligneous conjunctivitis and pseudomembraneous lesions due to impaired fibrin clearance 1, while elevated PLG expression promotes hepatocellular carcinoma progression through enhanced anoikis resistance and cell migration 4. In gastric cancer, PLG expression inversely correlates with immune cell infiltration, suggesting immunosuppressive function 5. Periodontal disease associations highlight PLG's importance in wound healing; congenital PLG deficiency increases periodontitis risk, and genetic variants at PLG interact with other loci to regulate wound healing processes 67. Additionally, PLG enhances dengue virus type 2 infection in mosquito vectors [UniProt reference]. These findings establish PLG as a multifunctional protein with roles spanning hemostasis, inflammation resolution, tissue repair, and disease pathogenesis.

Sources cited
1
Severe hypoplasminogenemia causes ligneous conjunctivitis and compromised extracellular fibrin clearance during wound healing
PMID: 17900274
2
Plg-RKT is a plasminogen receptor with C-terminal lysine that tethers plasminogen and promotes its activation to plasmin
PMID: 32662180
3
Plasminogen/plasmin system regulates inflammation resolution, extracellular matrix degradation, and immune cell migration
PMID: 37495082
4
PLG facilitates anoikis resistance and enhances hepatocellular carcinoma cell migration as a tumor promoter
PMID: 39633373
5
PLG expression in gastric cancer inversely correlates with immune cell infiltration
PMID: 36376702
6
Congenital PLG deficiency predisposes to severe periodontitis due to defective fibrinolysis
PMID: 40740136
7
PLG genetic variants interact with lncRNA CTD-2353F22.1 to regulate periodontal wound healing genes
PMID: 36129033
Disease Associationsβ“˜22
hypoplasminogenemiaOpen Targets
0.82Strong
hereditary angioedemaOpen Targets
0.73Strong
dysplasminogenemiaOpen Targets
0.66Moderate
hemorrhageOpen Targets
0.61Moderate
MenorrhagiaOpen Targets
0.58Moderate
hepatic veno-occlusive diseaseOpen Targets
0.57Moderate
coronary artery diseaseOpen Targets
0.56Moderate
myocardial infarctionOpen Targets
0.55Moderate
hemophilia AOpen Targets
0.51Moderate
Recurrent thrombophlebitisOpen Targets
0.50Moderate
cardiovascular diseaseOpen Targets
0.49Moderate
atrial fibrillationOpen Targets
0.49Moderate
hemorrhagic diseaseOpen Targets
0.47Moderate
HypercholesterolemiaOpen Targets
0.46Moderate
hyperlipidemiaOpen Targets
0.45Moderate
blood coagulation diseaseOpen Targets
0.44Moderate
heart diseaseOpen Targets
0.44Moderate
metabolic syndromeOpen Targets
0.42Moderate
postpartum hemorrhageOpen Targets
0.41Moderate
Myocardial IschemiaOpen Targets
0.41Moderate
Angioedema, hereditary, 4UniProt
Plasminogen deficiencyUniProt
Pathogenic Variants28
NM_000301.5(PLG):c.112A>G (p.Lys38Glu)Pathogenic
Plasminogen deficiency, type I|not provided|Otitis media, susceptibility to|Deep venous thrombosis|Angioedema, hereditary, 4|Plasminogen deficiency, type I;Angioedema, hereditary, 4
β˜…β˜…β˜†β˜†2026β†’ Residue 38
NM_000301.5(PLG):c.988A>G (p.Lys330Glu)Pathogenic
Hereditary angioneurotic edema|Angioedema, hereditary, 4|not provided|PLG-related disorder|Plasminogen deficiency, type I;Angioedema, hereditary, 4
β˜…β˜…β˜†β˜†2026β†’ Residue 330
NM_000301.5(PLG):c.1588-1G>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2026
NM_000301.5(PLG):c.732G>A (p.Trp244Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 244
NM_000301.5(PLG):c.1675C>T (p.Gln559Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 559
NM_000301.5(PLG):c.528C>A (p.Cys176Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 176
NM_000301.5(PLG):c.1755T>A (p.Cys585Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 585
NM_000301.5(PLG):c.292+1G>CLikely pathogenic
Angioedema, hereditary, 4;Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†2024
NM_000301.5(PLG):c.1987C>T (p.Arg663Ter)Likely pathogenic
Angioedema, hereditary, 4;Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†2024β†’ Residue 663
NM_000301.5(PLG):c.948C>A (p.Cys316Ter)Likely pathogenic
Angioedema, hereditary, 4;Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†2024β†’ Residue 316
NM_000301.5(PLG):c.763del (p.Glu255fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 255
NM_000301.5(PLG):c.910C>G (p.Pro304Ala)Likely pathogenic
Angioedema, hereditary, 4;Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†2024β†’ Residue 304
NM_000301.5(PLG):c.1468C>T (p.Arg490Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 490
NM_000301.5(PLG):c.1256+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_000301.5(PLG):c.1265dup (p.Met423fs)Likely pathogenic
PLG-related disorder
β˜…β˜†β˜†β˜†2022β†’ Residue 423
NM_000301.5(PLG):c.293-2A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_000301.5(PLG):c.618C>A (p.Cys206Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 206
NM_000301.5(PLG):c.2019-1G>ALikely pathogenic
Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†2021
NM_000301.5(PLG):c.185+1G>TPathogenic
not provided
β˜…β˜†β˜†β˜†2015
NM_000301.5(PLG):c.677del (p.Asn226fs)Likely pathogenic
Plasminogen deficiency, type I
β˜…β˜†β˜†β˜†β†’ Residue 226
View on ClinVar β†—
Drug Targets9
AMEDIPLASEPhase III
Plasminogen activator
myocardial infarction
AMINOCAPROIC ACIDApproved
Plasminogen inhibitor
hemorrhage
ANISTREPLASEApproved
Plasminogen activator
Recurrent thrombophlebitis
APROTININApproved
Plasminogen inhibitor
hemorrhage
DEFIBROTIDEApproved
Adenosine A2 receptor agonist
Recurrent thrombophlebitis
DEFIBROTIDE SODIUMApproved
Plasminogen activator
spondylo-ocular syndrome
DESMOTEPLASEPhase III
Plasminogen activator
Ischemic stroke
STREPTOKINASEApproved
Plasminogen activator
Recurrent thrombophlebitis
TRANEXAMIC ACIDApproved
Plasminogen inhibitor
Menorrhagia
Related Genes
F12Protein interaction100%KNG1Protein interaction100%CTSBProtein interaction100%SERPINB2Protein interaction100%SERPINE2Protein interaction100%CLEC3BProtein interaction100%
Tissue Expression6 tissues
Liver
100%
Ovary
0%
Lung
0%
Brain
0%
Bone Marrow
0%
Heart
0%
Gene Interaction Network
Click a node to explore
PLGF12KNG1CTSBSERPINB2SERPINE2CLEC3B
PROTEIN STRUCTURE
Preparing viewer…
PDB5UGG Β· 1.20 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.56Moderately Constrained
pLIβ“˜
0.17Tolerant
Observed/Expected LoF0.42 [0.31–0.56]
RankingsWhere PLG stands among ~20K protein-coding genes
  • #630of 20,598
    Most Researched440 Β· top 5%
  • #205of 1,025
    FDA-Approved Drug Targets7 Β· top quartile
  • #1,862of 5,498
    Most Pathogenic Variants28
  • #3,625of 17,882
    Most Constrained (LOEUF)0.56 Β· top quartile
Genes detectedPLG
Sources retrieved27 papers
Response timeβ€”
πŸ“„ Sources
27β–Ό
1
Plasminogen deficiency.
PMID: 17900274
J Thromb Haemost Β· 2007
1.00
2
Functions of the plasminogen receptor Plg-R
PMID: 32662180
J Thromb Haemost Β· 2020
0.90
3
Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma.
PMID: 39633373
J Transl Med Β· 2024
0.80
4
Plg-R
PMID: 35454092
Biomolecules Β· 2022
0.72
5
New insights into the role of Plg-RKT in macrophage recruitment.
PMID: 24529725
Int Rev Cell Mol Biol Β· 2014
0.70